About JAGGI ENTERPRISES PRIVATE LIMITED
JAGGI ENTERPRISES PRIVATE LIMITED is a Private Limited Company and was incorporated on May 18, 2017 in India. It is registered at Registrar of Companies, ROC Delhi. Its registered address is A-7, First Floor, Mayapuri Industrial Area, Phase-II, Maya Puri, West Delhi, New Delhi, Delhi, India, 110064. Its corporate identification number is (CIN) U74999DL2017PTC317744 and its current status is Active. Its industry classification as per MCA is other Business Activities N.E.C. It had a team size of 144 employees as on Feb 29, 2024.
JAGGI ENTERPRISES PRIVATE LIMITED's last Annual General Meeting (AGM) was held on Sep 17, 2025 as per records from Ministry of Corporate Affairs (MCA). JAGGI ENTERPRISES PRIVATE LIMITED's authorised share capital is ₹1L and its paid up capital is ₹1L. The current board of directors of JAGGI ENTERPRISES PRIVATE LIMITED comprises Amar Nath Lalka and Amitabh Bhatnagar.
JAGGI ENTERPRISES PRIVATE LIMITED generated between ₹100 Cr and ₹500 Cr in revenue for the financial year ending on Mar 31, 2025.
Key Metrics
CIN
U74999DL2017PTC317744
Location
Current Status
Active
Entity Type
Private Limited Company
Date Of Incorporation
May 18, 2017
Company Age
9 Years 2 Months
Registrar of Companies
ROC - Delhi
Last AGM Date
Sep 17, 2025
Latest Revenue
₹100 - ₹500 Cr as on Mar 31, 2025
Latest Employee Count
144 as on Feb 29, 2024
Authorized Capital
₹1L
Paid Up Capital
₹1L
Contact Details for JAGGI ENTERPRISES PRIVATE LIMITED
- *****@gmail.com, *****@ehspl.com
- Registered Address
- A-7, First Floor, Mayapuri Industrial Area, Phase-II, Maya Puri, West Delhi, New Delhi, Delhi, India, 110064
Brands associated with JAGGI ENTERPRISES PRIVATE LIMITED
There is one brand associated with JAGGI ENTERPRISES PRIVATE LIMITED which include ehspl.com .
Name | Short Description | Founded Year | Location | Current Stage |
|---|---|---|---|---|
Provider of distribution services for pharmaceutical and healthcare products | - | - | Unfunded |
Principal Business Activity of JAGGI ENTERPRISES PRIVATE LIMITED
The majority of JAGGI ENTERPRISES PRIVATE LIMITED's turnover comes from Wholesale and retail trade; repair of motor vehicles and motorcycles.
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | ese |
Documents of JAGGI ENTERPRISES PRIVATE LIMITEDFY 25 Available15 mins
15 minsFiling Summary
Here is a summary of filing activity and document availability across financial years:
File Type | FY 24-25 | FY 23-24 | FY 22-23 | FY 21-22 | FY 20-21 |
|---|---|---|---|---|---|
Financial Statements | |||||
Annual Returns |
Latest Financials, Share Allotment and Annual Report
The latest filed financial documents, annual reports, and share allotment filings are shown below:
Recent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
Form MSME | Other eForm Documents | Apr 17, 2026 |
INC-34 e-AOA | Incorporation | Mar 11, 2026 |
Form MGT-14 | Other eForm Documents | Mar 11, 2026 |
Optional attachment(s) - if any | Other eForm Documents | Mar 11, 2026 |
Copy(s) of resolution(s) along with copy of explanatory statement under section 173 | Other eForm Documents | Mar 11, 2026 |
Instrument(s) of creation or modification of charge | Charges | Feb 27, 2026 |
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE | Certificates | Feb 27, 2026 |
Form CHG-1 | Charges | Feb 27, 2026 |
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Dec 09, 2025 |
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Dec 09, 2025 |
To access all company documents and filings with a single purchase, Buy Financials and Company Filings FY 25 Available15 mins
Financials of JAGGI ENTERPRISES PRIVATE LIMITEDFY 25 Available15 mins
JAGGI ENTERPRISES PRIVATE LIMITED generated between ₹100 Cr and ₹500 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of JAGGI ENTERPRISES PRIVATE LIMITED has a compounded annual growth rate (CAGR) of 8% in the last 1 year.
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 3965 | 7788 | 5906 | 1415 | 2162 |
Total Sales | 2450 | 2533 | 5755 | 5277 | 8114 |
Total Expenses | 2792 | 6488 | 2321 | 5036 | 3224 |
Operating Expenses | 9672 | 3534 | 6167 | 8248 | 9685 |
Employee Expenses | 6841 | 7474 | 3186 | 4553 | 9077 |
Marketing Expenses | 9268 | 8427 | 4452 | 8572 | 1984 |
Operating Income (EBIT) | 3718 | 5448 | 3046 | 6965 | 3220 |
Interest Expenses | 2194 | 5891 | 3988 | 3665 | 5187 |
Expenses from other activities | 7040 | 2568 | 5953 | 3295 | 4935 |
EBITDA | 2992 | 5736 | 9068 | 9565 | 6175 |
Taxes | 4677 | 7436 | 4030 | 7299 | 6725 |
Net Profit | 2930 | 6132 | 2490 | 8624 | 9777 |
Balance Sheet | |||||
Assets | 7263 | 1064 | 7037 | 8660 | 7140 |
Cash Equivalent | 7939 | 2444 | 9784 | 3493 | 5262 |
Accounts Receivables | 1768 | 8920 | 2923 | 3447 | 8832 |
Inventory | 8559 | 7888 | 4106 | 3494 | 7496 |
Liabilities | 2733 | 2936 | 4291 | 9114 | 8392 |
Total Debt | 1952 | 6643 | 4176 | 3009 | 6159 |
Accounts Payable | 9035 | 7058 | 9507 | 6075 | 1448 |
Equities | 7014 | 4191 | 9834 | 1515 | 5793 |
Cashflow Statement | |||||
Cash from Operating activities | 2966 | 4997 | 3131 | 6835 | 5220 |
Cash from Investing activities | 7001 | 1194 | 5166 | 8561 | 6974 |
Net cash from Financing activities | 6520 | 8949 | 3443 | 4907 | 5054 |
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Profitability Ratios | |||||
EBITDA Margin | 2241 | 3108 | 8933 | 5106 | 8878 |
EBIT Margin | 3089 | 8314 | 7084 | 8858 | 5540 |
Net Profit Margin | 8540 | 6083 | 9058 | 8888 | 8669 |
Return on Assets (ROA) | 9176 | 1696 | 4667 | 6383 | 5137 |
Return on Equity (ROE) | 4388 | 1145 | 2758 | 3833 | 9461 |
Return on Capital Employed | 6226 | 3350 | 7111 | 8412 | 7806 |
Return on Invested Capital | 7631 | 6208 | 3509 | 2124 | 1962 |
Efficiency Ratios | |||||
Asset Turnover | 1830 | 3226 | 9679 | 8448 | 2316 |
Receivables Turnover | 1347 | 9201 | 9424 | 5800 | 4639 |
Days Sales Outstanding | 9630 | 8317 | 4934 | 8572 | 7531 |
Inventory Turnover | 3199 | 1437 | 7584 | 2908 | 1063 |
Days Inventory Outstanding | 6180 | 5531 | 5955 | 7986 | 8176 |
Payables Turnover | 7356 | 5256 | 3396 | 8544 | 1048 |
Days Payables Outstanding | 1768 | 7944 | 3878 | 3285 | 3758 |
Liquidity Ratios | |||||
Current Ratio | 2769 | 6453 | 5792 | 5247 | 2704 |
Quick Ratio | 1145 | 2051 | 3109 | 4872 | 4685 |
Cash Ratio | 2649 | 8521 | 3008 | 6951 | 1948 |
Coverage Ratios | |||||
Cash Flow Coverage Ratio | 3281 | 8782 | 3226 | 2928 | 7225 |
Debt Ratios | |||||
Debt-to-Equity Ratio | 1798 | 2157 | 2617 | 9856 | 7847 |
Debt Ratio | 3448 | 4643 | 2857 | 7738 | 3218 |
Net Debt | 5276 | 9902 | 3788 | 8521 | 6524 |
Interest Coverage Ratio | 1874 | 3705 | 6087 | 5099 | 7421 |
Debt Service Coverage Ratio | 2654 | 3639 | 1813 | 1481 | 4544 |
Net Debt/EBITDA | 3839 | 8663 | 2266 | 3071 | 1124 |
Growth Ratios | |||||
Revenue Growth Rate (CAGR) | 6263 | 2331 | 5098 | 3865 | 3085 |
Earnings Growth Rate (CAGR) | 4751 | 9229 | 3211 | 9540 | 8075 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of JAGGI ENTERPRISES PRIVATE LIMITED
Revenue CAGR | Growth |
|---|---|
1 Year | 8% |
3 Year | 324 |
5 Year | 912 |
EBITDA CAGR | Growth |
|---|---|
1 Year | -120% |
3 Year | 614 |
5 Year | 176 |
MSME Payment Delays by JAGGI ENTERPRISES PRIVATE LIMITED
There are 5 delayed MSME payments recorded for JAGGI ENTERPRISES PRIVATE LIMITED during Oct 2025 - Mar 2026.
Here are the details of MSME payment delays for this period:
Supplier Name | Supplier PAN | Amount Due | Due since |
|---|---|---|---|
SPANDAN PHARMACEUTICALS | 3312 | 9984 | 6600 |
DIAGNOSTIC TRADERS | 1646 | 8560 | 4966 |
CARE
BELLS
PHARMA
CEUTICA
LS | 6652 | 6557 | 2587 |
DERMCURES PHARMA | 1738 | 2130 | 1983 |
BITCO
PHARMA
CEUTICAL
PRIVATE
LIMITED | 6421 | 6786 | 3143 |
To access detailed supplier-wise and period-wise MSME payment delay information, Buy Detailed Report
Loans and Charges on JAGGI ENTERPRISES PRIVATE LIMITED
JAGGI ENTERPRISES PRIVATE LIMITED
has taken 1 loan.
Here is a list of loans and charges on JAGGI ENTERPRISES PRIVATE LIMITED:
As a Borrower
Loan/ Charge ID | Lender Name | Loan Amount | Status | Creation Date | Closure Date |
|---|---|---|---|---|---|
100395429 | ₹12Cr | swfxykp | Oct 05, 2020 | yyneutm |
To access detailed information on a company’s loans, borrowings, & registered charges, Buy Detailed Report
Credit Ratings of JAGGI ENTERPRISES PRIVATE LIMITED
GSTIN Details of JAGGI ENTERPRISES PRIVATE LIMITED
Board of Directors and Signatories of JAGGI ENTERPRISES PRIVATE LIMITED
Board of Directors of JAGGI ENTERPRISES PRIVATE LIMITED
Here is the list of current board of directors of JAGGI ENTERPRISES PRIVATE LIMITED:
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Jun 25, 2025 | 1 Year | |
Additional Director | Current | Oct 17, 2025 | 9 Months |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Signatories of JAGGI ENTERPRISES PRIVATE LIMITED
Here is the list of current signatories of JAGGI ENTERPRISES PRIVATE LIMITED:
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Jun 25, 2025 | 1 Year | |
Additional Director | Current | Oct 17, 2025 | 9 Months |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Cross Directorships of JAGGI ENTERPRISES PRIVATE LIMITED
JAGGI ENTERPRISES PRIVATE LIMITED has directors who also hold positions in 3 other legal entities. All are listed below:
Legal Entity Name | % of Common Directors | Common Director(s) | Open Charge(s) | Active Legal Case(s) |
|---|---|---|---|---|
ATREJA HEALTHCARE SOLUTIONS PRIVATE LIMITED CIN: U51909HR2021PTC092908, India, Active | 396 | 427 | 431 | 959 |
SHARAMIT ENTERPRISES PRIVATE LIMITED CIN: U74999HR2017PTC067765, India, Active | 513 | 126 | 816 | 552 |
MILLENNIUM MEDISOLUTIONS PRIVATE LIMITED CIN: U74999HR2018PTC076964, India, Active | 909 | 263 | 839 | 112 |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Legal Cases involving JAGGI ENTERPRISES PRIVATE LIMITED
Employee Count of JAGGI ENTERPRISES PRIVATE LIMITED
JAGGI ENTERPRISES PRIVATE LIMITED has an employee count of 144 as on Feb 29, 2024.
Date | Employee Count |
|---|---|
Feb 24 | 144 |
Jan 24 | 668 |
Dec 23 | 991 |
Nov 23 | 112 |
Oct 23 | 856 |
Sep 23 | 635 |
Aug 23 | 235 |
Trademarks of JAGGI ENTERPRISES PRIVATE LIMITED
Patents of JAGGI ENTERPRISES PRIVATE LIMITED
Competitors & Alternates of JAGGI ENTERPRISES PRIVATE LIMITED
ehspl.com is the only brand associated with JAGGI ENTERPRISES PRIVATE LIMITED, and here are its Top 10 competitors ranked by Tracxn score:
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AmerisourceBergen 1985, Chesterbrook (United States), Public | Drug Corporation | - | 71/100 | |
2nd |  Entero Healthcare 2018, Mumbai (India), Public | Operator of an integrated healthcare products distribution platform | $59.7M | 66/100 | |
3rd |  EBOS Group 1922, Docklands (Australia), Public | Wholesaler & distributor of healthcare, medical, and pharmaceutical products | - | - | 61/100 |
4th |  Cencora 2001, Conshohocken (United States), Public | Provider of clinical trial logistics and other biopharma outsourcing services | - | - | 57/100 |
5th | CHEPLAPHARM 1998, Mesekenhagen (Germany), Late Stage | Pharmaceutical company that specializes in the development, marketing, and distribution of branded pharmaceutical products | $547M | 52/100 | |
6th |  Target Healthcare 2012, East Kilbride (United Kingdom), Series B | Distributor of pharmaceutical products | $26.1M | 51/100 | |
7th | Pharmaceutical distributor of temperature-sensitive medicines | $16.6M | 50/100 | ||
8th | Dizal Pharma 2017, Pudong (China), Series A | Limited information available | $100M | 50/100 | |
9th | Renee 2021, Los Angeles (United States), Seed | Distributor of diversified drugs | $8.2M | 48/100 | |
10th | Wellgistics Health 2022, Tampa (United States), Public | Provider of pharmaceutical logistics and technology solutions for prescription fulfillment | - | - | 48/100 |
4180th |  ehspl.com Unfunded | Provider of distribution services for pharmaceutical and healthcare products | - | - | 16/100 |
To view the full list of competitors of ehspl.com, Buy Detailed Report
FAQs about JAGGI ENTERPRISES PRIVATE LIMITED
Explore our recently published Legal Entities
